darunavir has been researched along with emtricitabine, tenofovir disoproxil fumarate drug combination in 3 studies
| Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (emtricitabine, tenofovir disoproxil fumarate drug combination) | Trials (emtricitabine, tenofovir disoproxil fumarate drug combination) | Recent Studies (post-2010) (emtricitabine, tenofovir disoproxil fumarate drug combination) |
|---|---|---|---|---|---|
| 1,148 | 224 | 780 | 254 | 31 | 213 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adriaenssen, I; Brogan, AJ; Manuel, SA; Mauskopf, JA; Smets, E | 1 |
| De Saram, S; Dhairyawan, R; Flanagan, S | 1 |
| Brown, K; Cunningham, D; De Wit, S; Eron, JJ; Hufkens, V; Jezorwski, J; Lathouwers, E; Opsomer, M; Orkin, C; Petrovic, R; Post, FA; Pulido, F; Van Landuyt, E | 1 |
1 trial(s) available for darunavir and emtricitabine, tenofovir disoproxil fumarate drug combination
| Article | Year |
|---|---|
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/
Topics: Adenine; Adult; Aged; Alanine; Anti-HIV Agents; Cobicistat; Darunavir; Drug Combinations; Drug Substitution; Emtricitabine; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Protease Inhibitors; Sustained Virologic Response; Tablets; Tenofovir; Treatment Outcome; Viral Load | 2019 |
2 other study(ies) available for darunavir and emtricitabine, tenofovir disoproxil fumarate drug combination
| Article | Year |
|---|---|
Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in Canada.
Topics: Adult; Antiretroviral Therapy, Highly Active; Canada; CD4 Lymphocyte Count; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Darunavir; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lopinavir; Markov Chains; Ritonavir | 2014 |
Extremely high HIV-1 viral load in a patient with undiagnosed clinical indicator disease for HIV infection.
Topics: AIDS Dementia Complex; Anti-HIV Agents; Black People; CD4 Lymphocyte Count; Darunavir; Delayed Diagnosis; Dermatitis, Atopic; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV-1; Humans; Immunosuppressive Agents; Middle Aged; Predictive Value of Tests; Prednisolone; Raltegravir Potassium; Ritonavir; Treatment Outcome; Viral Load | 2015 |